• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Organisation › Details

Numares AG

numares AG, based in Regensburg, Germany, is an innovative diagnostics company that applies machine learning to metabolomics data to develop advanced analytical tests for high-throughput use in clinical diagnostics. The AXINON® System employs advanced nuclear magnetic resonance (NMR) spectroscopy to evaluate metabolic constellations. Magnetic Group Signaling (MGS®) is a proprietary technology that enables NMR for highly standardized and rapid throughput testing. Metabolic tests stand as an important pillar in precision medicine to address unmet needs in cardiovascular, kidney, liver, and neurological diseases. *

 

	Start	2014-06-13 reorganised
	Group	Numares (Group)
	Predecessor	Numares GmbH
	Industry	NMR spectroscopy
	Industry 2	analytical services
	Person	Pfahlert, Volker (LipoFIT GmbH 201001– Managing Director COO before Roche Diagnostics + Dräger Medical)
	Person 2	Gibbons, Winton (Numares 202006– President Numares Group Corp before Agena Bioscience + Siloam Biosciences + Nanosphere)
	Region	Regensburg
	Country	Germany
	Street	9 Am BioPark
	City	93053 Regensburg
	Tel	+49-941-280-949-00
		Address record changed: 2020-12-02
Basic data	Employees	C: 51 to 100 (2017-09-07)
		* Document for �About Section�: Numares AG. (3/24/21). "Press Release: Numares Announces FDA 510(k) Submission of Axinon System, a NMR Platform for Metabolomics-based, AI-driven Diagnostics". Boston, MA & Regensburg.
		Record changed: 2021-06-05

Advertisement

More documents for Numares (Group)

• [1] Numares AG. (3/24/21). "Press Release: Numares Announces FDA 510(k) Submission of Axinon System, a NMR Platform for Metabolomics-based, AI-driven Diagnostics". Boston, MA & Regensburg....
• [2] Numares AG. (1/21/21). "Press Release: Numares and Bruker Sign Agreement to Enable Advanced Metabolomics-based Clinical Diagnostics". Boston, MA & Regensburg....
• [3] Numares AG. (6/8/20). "Press Release: Numares Announces Winton Gibbons as New President of US Subsidiary". Regensburg....
• [4] Numares AG. (11/8/19). "Press Release: University Hospital Regensburg and Numares Present Results for Detection of Acute Kidney Transplant Rejection Based on a Simple Urine Test". Regensburg....
• [5] Numares AG. (9/10/19). "Press Release: Numares Elects Kathy L. Bates as New Member of the Supervisory Board". Regensburg....
• [6] Numares AG. (2/5/19). "Press Release: Numares and Mayo Clinic Laboratories Announce Collaboration to Develop New Diagnostic Tests Using Distinctive Nuclear Magnetic Resonance Technology". Regensburg & Rochester, MN....
• [7] Numares AG. (5/18/18). "Press Release: Numares Initiates Pan-European Multicenter Study of Axinon renalTX-Score on Kidney Allograft Rejection". Regensburg....
• [8] Numares AG. (7/11/17). "Press Release: Numares AG Achieves Key Milestone – Identifies Candidate Metabolomic Network for Bladder Cancer Diagnostics". Regensburg....
• [9] Numares AG. (4/4/17). "Press Release: Numares Announces Commercial Launch of renalTX-SCORE". Regensburg....
• [10] Numares AG. (3/23/17). "Press Release: Numares AG and Oxford University to Collaborate on Development of Multiple Sclerosis Diagnostic Test". Regensburg & Oxford....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.